BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 6, 2012
View Archived Issues
Phase Ib/IIa study of ISIS-SMNRx commences
Read More
Biogen Idec and Sobi report topline results from phase III A-LONG trial
Read More
Preliminary results demonstrate good safety and efficacy for 3F8 + NK cells in neuroblastoma
Read More
Omeros begins enrollment in phase I trial evaluating OMS-824
Read More
Dynavax to begin phase I studies of TLR9 agonist for asthma
Read More
Portola, Bristol-Myers Squibb and Pfizer sign collaboration agreement
Read More
Navidea Biopharmaceuticals resubmits Lymphoseek NDA
Read More
Lilly Japan and Chugai to terminate Evista comarketing agreement in Japan
Read More
FDA approves Xarelto for use in three new indications
Read More
Addex reports topline data from second part of phase IIa ADX-71149 study
Read More
European authorities accept Ferring's MAA for MVDS in induction of labor
Read More
Biomedical Catalyst awards grants for development of healthcare technologies
Read More
PDA-001 induces clinical response in patients with Crohn's disease
Read More
Tesaro commences first clinical trial of its ALK inhibitor
Read More
[18F]-FE-PE2I investigated in healthy controls and patients with Parkinson's disease
Read More
Maresin 1 demonstrates analgesic activity
Read More
Vardenafil rescues CFTR function across rectal mucosa
Read More
New immunosuppressive compounds presented by Chinese researchers
Read More
Chinese group patents novel antipsychotic agents
Read More
Progress of EXC-001 triggers payment to Isis Pharmaceuticals
Read More
Bayer Schering Pharma synthesizes new protein kinase inhibitors
Read More
Siena Biotech presents new Wnt signaling inhibitors
Read More
Antitope to develop new biologic ANT-2034 for multiple sclerosis
Read More
Bioniche Life Sciences discontinues phase III Urocidin trial
Read More
Votubia obtains European approval for TSC-associated renal angiomyolipoma
Read More